These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 18300892

  • 21. Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas.
    Tabernero MD, Espinosa AB, Maillo A, Rebelo O, Vera JF, Sayagues JM, Merino M, Diaz P, Sousa P, Orfao A.
    Oncologist; 2007 Oct; 12(10):1225-36. PubMed ID: 17962616
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU, Ayan E, Bolukbasi F, Elmaci I, Pamir N, Sav A.
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [Abstract] [Full Text] [Related]

  • 23. Cytogenetic and proliferative potentials in meningiomas.
    Debiec-Rychter M, Biernat W, Limon J, Kordek R, Izycka E, Borowska-Lehman J, Imieliński B, Liberski PP.
    Pol J Pathol; 1999 Sep; 50(4):243-8. PubMed ID: 10721264
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.
    Tamiolakis D, Papadopoulos N, Lambropoulou M, Kotini A, Simopoulos C.
    Minerva Med; 2003 Feb; 94(1):51-6. PubMed ID: 12719702
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
    Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M.
    J Neurosurg; 2004 Aug; 101(2):210-8. PubMed ID: 15309910
    [Abstract] [Full Text] [Related]

  • 28. Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9.
    Okuducu AF, Zils U, Michaelis SA, Mawrin C, von Deimling A.
    Cancer; 2006 Sep 15; 107(6):1365-72. PubMed ID: 16894529
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome.
    Krayenbühl N, Pravdenkova S, Al-Mefty O.
    Neurosurgery; 2007 Sep 15; 61(3):495-503; discussion 503-4. PubMed ID: 17881961
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.
    Bollag RJ, Vender JR, Sharma S.
    Neuropathology; 2010 Jun 15; 30(3):279-87. PubMed ID: 19780983
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.